BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Halo Therapeutics LLC

Headquarters: Newton, MA, United States
Website: N/A
Year Founded: 2011
Status: Merged

BioCentury | Jul 29, 2013
Clinical News

HT-100: Phase Ib/IIa started

BioCentury | Jun 3, 2013
Product Development

The DMD landscape

Looking beyond the first Duchenne muscular dystrophy therapies
BioCentury | Mar 11, 2013
Product Development

Neomics' new tricks

Neomics targets new functions of aminoacyl tRNA synthetases for cancer
BioCentury | May 28, 2012
Company News

Halo Therapeutics musculoskeletal news

BioCentury | May 14, 2012
Clinical News

Halofuginone regulatory update

BioCentury | Mar 15, 2012
Targets & Mechanisms

Halofuginone target ID

BioCentury | Mar 8, 2012
Distillery Therapeutics

Indication: Autoimmune Disease

BioCentury | Mar 8, 2012
Distillery Therapeutics

Indication: Musculoskeletal disease

BioCentury | Feb 13, 2012
Emerging Company Profile

Halo: Treating DMD symptoms

Halo targeting Duchenne Muscular Dystrophy with patient group funding
Items per page:
1 - 10 of 11
Help Center
Username
Request Training
Submit Data Correction
Ask a Question